Company Filing History:
Years Active: 2001
Title: Kuniaki Tatsuta: Innovator in Pharmaceutical Compounds
Introduction
Kuniaki Tatsuta is a notable inventor based in Shinjuku-Ku, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have therapeutic applications. His work focuses on innovative solutions for progesterone-related diseases.
Latest Patents
Kuniaki Tatsuta holds a patent for "Tetrahydronaphthofuranone derivatives and process for producing the same." This patent describes compounds represented by a specific formula and their pharmaceutically acceptable salts. The compounds exhibit progesterone receptor binding inhibitory activity, making them valuable as therapeutic and prophylactic agents for various conditions. They are particularly useful as abortifacients, oral contraceptive pills, and carcinostatic agents for breast and ovarian cancer. Additionally, they serve as therapeutic agents for endometriosis, meningioma, myeloma, osteoporosis, and climacteric disturbances.
Career Highlights
Kuniaki Tatsuta is associated with Meiji Seika Kaisha, Ltd., where he continues to contribute to pharmaceutical innovations. His work has led to advancements in the treatment of several serious health conditions, showcasing his commitment to improving patient outcomes through scientific research.
Collaborations
Kuniaki has collaborated with notable colleagues, including Kenichi Kurihara and Rie Shinei. These partnerships have fostered a collaborative environment that enhances the development of innovative pharmaceutical solutions.
Conclusion
Kuniaki Tatsuta's contributions to the field of pharmaceuticals through his innovative patents highlight his role as a significant inventor. His work not only advances scientific knowledge but also provides essential therapeutic options for patients facing progesterone-related health issues.